Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.14797/mdcj-14-1-7 http://scihub22266oqcxt.onion/10.14797/mdcj-14-1-7 C5880567!5880567!29623167     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Methodist+Debakey+Cardiovasc+J 2018 ; 14 (1): 7-13 Nephropedia Template TP {{tp|p=29623167|t=2018. Current Indications for Stenting: Symptoms or Survival CME |pdf=|usr=}}{{29623167}} gab.com Text Current Indications for Stenting: Symptoms or Survival CME JO: Methodist Debakey Cardiovasc J http://www.kidney.de/pget.php?&tw=1&pmid=29623167 #FOAvip The major goals of treating ischemic heart disease are to reduce angina, improve quality of life, and ultimately reduce mortality. While medical therapy can effectively address these aims, there is still much research and debate about the role of percutaneous coronary intervention in the treatment spectrum?specifically, whether or not stenting prolongs life or simply treats symptoms without impacting survival. The data supporting revascularization for survival benefit came from patients who underwent bypass graft surgery prior to the introduction of effective medical management. Although both physicians and patients continue to believe in the life-saving ability of coronary stenting, little data exist to support this belief outside of when used during an acute myocardial infarction. Strategy trials designed to test the benefit of coronary stenting have limitations that have curbed physicians' willingness to accept the results, but they provide the best evidence for how to optimally manage these patients. In this article, we explore the data supporting the use of coronary stenting for various indications and the questions that remain to be answered. Twit Text FOAVip Current Indications for Stenting: Symptoms or Survival CME ????Methodist Debakey Cardiovasc J http://www.kidney.de/pget.php?&tw=1&pmid=29623167 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29623167 #FOAvip English Wikipedia <ref>{{Cite pmid|29623167}}</ref> Current Indications for Stenting: Symptoms or Survival CME #MMPMID29623167 Arnold SV Methodist Debakey Cardiovasc J 2018[Jan]; 14 (1): 7-13 PMID29623167show ga The major goals of treating ischemic heart disease are to reduce angina, improve quality of life, and ultimately reduce mortality. While medical therapy can effectively address these aims, there is still much research and debate about the role of percutaneous coronary intervention in the treatment spectrum?specifically, whether or not stenting prolongs life or simply treats symptoms without impacting survival. The data supporting revascularization for survival benefit came from patients who underwent bypass graft surgery prior to the introduction of effective medical management. Although both physicians and patients continue to believe in the life-saving ability of coronary stenting, little data exist to support this belief outside of when used during an acute myocardial infarction. Strategy trials designed to test the benefit of coronary stenting have limitations that have curbed physicians' willingness to accept the results, but they provide the best evidence for how to optimally manage these patients. In this article, we explore the data supporting the use of coronary stenting for various indications and the questions that remain to be answered. äCurrent Indications for Stenting: Symptoms or Survival CME (epmc).pdf DeepDyve Pubget Overpricing